International Biotechnology Trust’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
$17.5M Buy
233,584
+89,000
+62% +$6.67M 5.9% 3
2023
Q2
$11.1M Buy
144,584
+87,000
+151% +$6.7M 3.39% 11
2023
Q1
$4.78M Hold
57,584
1.33% 27
2022
Q4
$4.94M Sell
57,584
-151,200
-72% -$13M 1.53% 22
2022
Q3
$12.9M Buy
208,784
+199,772
+2,217% +$12.3M 4.13% 5
2022
Q2
$146K Sell
9,012
-79,772
-90% -$1.29M 1.52% 21
2022
Q1
$1.08M Sell
88,784
-194,000
-69% -$2.36M 0.24% 55
2021
Q4
$20.5M Sell
282,784
-120,000
-30% -$8.71M 4.57% 5
2021
Q3
$28.1M Hold
402,784
6.78% 1
2021
Q2
$27.7M Buy
402,784
+15,000
+4% +$1.03M 7.32% 1
2021
Q1
$25.1M Buy
387,784
+39,500
+11% +$2.55M 6.63% 2
2020
Q4
$20.3M Buy
348,284
+27,000
+8% +$1.57M 5.54% 6
2020
Q3
$20.3M Buy
321,284
+18,000
+6% +$1.14M 6.55% 3
2020
Q2
$22.6M Buy
303,284
+66,000
+28% +$4.92M 7.52% 3
2020
Q1
$17.7M Sell
237,284
-56,000
-19% -$4.18M 8.08% 2
2019
Q4
$19.1M Sell
293,284
-23,000
-7% -$1.49M 6.86% 2
2019
Q3
$20M Hold
316,284
9.26% 1
2019
Q2
$21.4M Buy
316,284
+38,000
+14% +$2.57M 7.92% 1
2019
Q1
$18.1M Buy
278,284
+65,000
+30% +$4.23M 6.68% 2
2018
Q4
$10.5M Buy
213,284
+123,000
+136% +$6.04M 6.5% 4
2018
Q3
$5.35M Hold
90,284
2.54% 16
2018
Q2
$6.4M Sell
90,284
-41,000
-31% -$2.91M 2.46% 17
2018
Q1
$9.9M Buy
131,284
+8,500
+7% +$641K 3.86% 9
2017
Q4
$8.8M Hold
122,784
3.1% 9
2017
Q3
$9.95M Buy
122,784
+1,000
+0.8% +$81K 3.87% 7
2017
Q2
$8.62M Buy
121,784
+20,000
+20% +$1.42M 3.28% 9
2017
Q1
$6.91M Sell
101,784
-74,000
-42% -$5.03M 2.65% 11
2016
Q4
$12.6M Buy
+175,784
New +$12.6M 5.67% 6